What Causes a Platelet Count of 124 × 10⁹/L?
A platelet count of 124 × 10⁹/L represents mild thrombocytopenia (defined as <150 × 10⁹/L) and is most commonly caused by immune thrombocytopenia (ITP), drug-induced thrombocytopenia, viral infections, or may represent incidental borderline thrombocytopenia in an otherwise healthy individual. 1
Primary Diagnostic Consideration: Rule Out Pseudothrombocytopenia First
Before pursuing extensive workup, you must exclude pseudothrombocytopenia by recollecting blood in a heparin or sodium citrate tube and repeating the platelet count 2. Pseudothrombocytopenia occurs when EDTA anticoagulant causes platelet clumping, artificially lowering the automated count. This is particularly important to consider if the patient has concurrent viral infection, as thrombocytopenic patients with viral infections have significantly higher rates of platelet clumping (13.8% vs 6.5%) 3.
Most Likely Causes Based on Clinical Context
If Patient is Otherwise Healthy and Asymptomatic:
Incidental borderline thrombocytopenia is the most likely diagnosis. In a prospective study of 191 healthy individuals with platelet counts between 100-150 × 10⁹/L:
- 64% maintained stable counts with no other disorders developing over 64 months of follow-up 4
- The 10-year probability of developing ITP (counts persistently <100 × 10⁹/L) was only 6.9%
- The 10-year probability of developing other autoimmune disorders was 12%, occurring predominantly in women (85% of cases) 4
If Patient Has Acute Illness or Symptoms:
Primary ITP is defined by the International Working Group as a platelet count <100 × 10⁹/L in the absence of other causes 1. However, at 124 × 10⁹/L, the patient falls into a borderline zone. ITP results from:
- Immunologic destruction of otherwise normal platelets
- Decreased platelet production (newer evidence challenges the old model of purely increased destruction) 1
Secondary causes to investigate 1:
- Viral infections: Hepatitis C, HIV, CMV, varicella zoster, hepatitis A (most common in viral-associated pseudothrombocytopenia)
- Autoimmune diseases: Antiphospholipid syndrome, systemic lupus erythematosus, Evans syndrome
- Drug-induced: Review all medications
- H. pylori infection: Should be screened for and treated if positive 1
- Lymphoproliferative disorders
- Common variable immune deficiency
Clinical Significance of This Platelet Count
At 124 × 10⁹/L, patients are generally asymptomatic and have minimal bleeding risk 2. The evidence shows:
- Patients with counts >50 × 10⁹/L are generally asymptomatic
- Treatment is rarely indicated with counts >50 × 10⁹/L unless specific risk factors exist 5
- Mild skin manifestations (petechiae, purpura) typically only occur with counts between 20-50 × 10⁹/L 2
Recommended Diagnostic Approach
Repeat platelet count in heparin or citrate tube to exclude pseudothrombocytopenia 2
Review previous platelet counts to distinguish acute from chronic thrombocytopenia 2
Targeted history focusing on:
- Bleeding symptoms (even minor bruising or petechiae)
- Medication review (all drugs, including over-the-counter)
- Viral illness symptoms
- Autoimmune disease symptoms
- Family history of thrombocytopenia or autoimmune disorders
If thrombocytopenia confirmed and persistent:
Management at This Platelet Level
No treatment is indicated for asymptomatic patients with a platelet count of 124 × 10⁹/L 5. The consensus guidelines are clear that treatment is rarely indicated above 50 × 10⁹/L in the absence of:
- Active bleeding
- Platelet dysfunction
- Planned surgery or invasive procedures
- Mandated anticoagulation therapy
- High-risk profession or lifestyle predisposing to trauma 5
Important Caveats:
- If female patient: Higher index of suspicion for eventual autoimmune disease development (85% of autoimmune cases in the borderline thrombocytopenia cohort were women) 4
- If viral infection present: Consider that platelet clumping may be contributing to the low count 3
- Observation is appropriate: Most cases either resolve spontaneously or persist without complications 4